In:
Immunotherapy, Future Medicine Ltd, Vol. 15, No. 9 ( 2023-06), p. 669-678
Abstract:
Tweetable abstract Results show that treatments containing immune checkpoint blockers are more effective for males, patients with macrovascular invasion and/or extrahepatic spread and viral-related hepatocellular carcinoma patients.
Type of Medium:
Online Resource
ISSN:
1750-743X
,
1750-7448
DOI:
10.2217/imt-2022-0114
Language:
English
Publisher:
Future Medicine Ltd
Publication Date:
2023